Luigi Lorini: What is the role of ICIs in patients excluded from clinical trials?

Luigi Lorini, Medical Oncologist at Humanitas Research Hospital, made the following post on LinkedIn:

“The introduction of ICIs has significantly altered the therapeutic scenario for patients with advanced cSCC.
Nevertheless, there are crucial aspects that need further exploration. How can ICIs be integrated into a curative setting? What is the role of ICIs in patients excluded from clinical trials?
You can find our latest manuscript on this intriguing topic here!”

Source: Luigi Lorini/LinkedIn